Gene Expression of CD226 and Its Serum Levels in Patients With Multiple Sclerosis

Journal Title: Caspian Journal of Neurological Sciences - Year 2018, Vol 4, Issue 14

Abstract

Background: Recent studies have found some genetic variants as a risk factor for autoimmune diseases such as Multiple Sclerosis (MS). Cluster of Differentiation 226 (CD226) is one of the risk factors for MS. Objectives: The present study aimed to evaluate the gene expression of CD226, and its protein serum level in peripheral blood samples of MS patients and healthy individuals. Materials & Methods: Thirty individuals with MS and 30 healthy individuals, as controls, referred to Kashani Hospital of Isfahan, Iran. CD226 expression at the transcript level and serum protein levels were measured by quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assays, respectively. Statistical analyses were performed by Shapiro-Wilk test and nonparametric tests in SPSS. Results: The present study showed no significant differences in the gene expression of CD226 (P=0.341). The mean serum protein level of CD226 was not different between the patients and the controls (P=0.978). Conclusion: Overall, CD226 expression has no diagnostic usefulness in MS at either the transcript or serum level. Keywords: Multiple Sclerosis, Demyelinating diseases, Gene expression, Cluster of Differentiation 226 (CD226) antigen

Authors and Affiliations

Fereshteh Alsahebfosoul, Shokofeh Rahimpourkoldeh, Nahid Eskandari, Vahid Shaygannejad, Mazdak Ganjalikhani Hakemi, Arezo Dabiri, Morteza Jafarnia, Omid Mirmossayeb

Keywords

Related Articles

Celecoxib or Prednisolone for Treatment of Medication Overuse Headache: A Randomized, Double-Blind Clinical Trial in Migrainous Patients

Background:Treatment of Medication Overuse Headache (MOH) is yet under debate and Celecoxib as a Cyclooxygenase 2 (COX2) -inhibitor has not been tried widely as a pain relief drug for this type of headaches in migrainous...

Psychopathological Symptoms in Caregivers of Patients With Vegetative State

Background: Taking care of patients in a vegetative state is a great challenge and affects the mental health of the caregivers. Objectives: This study aimed to determine the psychopathological symptoms in caregivers of p...

Sleep-Related Seizures in Refractory Focal Epilepsy: Electroclinical Findings and Surgical Outcome

Background: Sleep Seizures (SSs) generally occur in refractory focal epilepsy, but their detailed characteristics and circadian patterns are still controversial. The effect of SSs on epilepsy surgery outcome has been add...

Prevalence of Tremors in Patients With Multiple Sclerosis: A Cross-Sectional Study in Isfahan, Iran

Background: Multiple Sclerosis (MS) is a demyelinating disorder of the central nervous system. Tremors are a common problem in the patients suffering from MS which is mostly observed in the arms but can also affect the o...

The Impact of Word Regularity on the Reading of Normal and Aphasic Gilak-Persian Adults

Background: Various factors influence the natural processing of words. The present study sought to investigate the effect of the regularity variable on the reading of words. Objectives: The participants in the study were...

Download PDF file
  • EP ID EP434402
  • DOI 10.29252/cjns.4.14.91
  • Views 113
  • Downloads 0

How To Cite

Fereshteh Alsahebfosoul, Shokofeh Rahimpourkoldeh, Nahid Eskandari, Vahid Shaygannejad, Mazdak Ganjalikhani Hakemi, Arezo Dabiri, Morteza Jafarnia, Omid Mirmossayeb (2018). Gene Expression of CD226 and Its Serum Levels in Patients With Multiple Sclerosis. Caspian Journal of Neurological Sciences, 4(14), -. https://europub.co.uk/articles/-A-434402